Catalyst Wire Dossier Catalyst Wire Dossier

TYBLUME

levonorgestrel and ethinyl estradiol · Exeltis USA, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TYBLUME, covering 2020-03-30 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: TYBLUME — Supplemental Application (Exeltis USA, Inc.)

See pricing